Adaptation of leukemia cells to hypoxic condition through switching the energy metabolism or avoiding the oxidative stress by Mineaki Goto et al.
Goto et al. BMC Cancer 2014, 14:76
http://www.biomedcentral.com/1471-2407/14/76RESEARCH ARTICLE Open AccessAdaptation of leukemia cells to hypoxic condition
through switching the energy metabolism or
avoiding the oxidative stress
Mineaki Goto1, Hiroshi Miwa1*, Kazuto Suganuma1, Norikazu Tsunekawa-Imai1, Masato Shikami2,
Motonori Mizutani1, Shohei Mizuno1, Ichiro Hanamura1 and Masakazu Nitta1Abstract
Background: Like normal hematopoietic stem cells, leukemia cells proliferate in bone marrow, where oxygen
supply is limited. However, the growth and energy metabolism of leukemia cells under hypoxia have not been well
understood. Although it has been known that reactive oxygen species (ROS) is generated under hypoxic conditions,
normal and leukemia stem cells were characterized by relatively low levels of ROS. Roles of ROS on leukemia cells
under hypoxia also have not been well understood.
Methods: Four Leukemia cell lines were cultured under normoxia (21% O2) or hypoxia (1% O2), where NB4 and THP-1
were most extensively studied. To evaluate energy metabolism, we estimated whole cell number or apoptotic cells
with or without a glycolysis inhibitor or an oxidative phosphorylation (OXPHOS) inhibitor. Glucose consumption and
lactate production were also measured. To evaluate oxidative stress in hypoxic condition, the ROS level and GSH
(reduced glutathione) / GSSG (oxidized glutathione) ratio was measured. In addition, pyruvate dehydrogenase kinase 1
(PDK1) and cytochrome c oxidase subunit 4 (COX4) were examined by western blotting or RT-PCR.
Results: NB4, which grows well under normoxia depending on glycolysis, demonstrated prominent apoptosis and
growth suppression after 48 hours culture under hypoxia. NB4 cells cultured under hypoxia showed significantly
increased ROS. Culture with a ROS scavenger resulted in decrease of apoptotic cell death of NB4 under hypoxia. NB4
cells cultured for longer period (7 days) under hypoxia did not come to extinction, but grew slowly by upregulating
GSH synthesis to protect from ROS generated in hypoxic condition. By contrast, THP-1, which largely depends on
OXPHOS in mitochondria under normoxia, demonstrated more growth under hypoxia by changing metabolism from
OXPHOS to glycolysis through upregulating PDK1. Moreover, THP-1 avoided ROS generation by substituting COX 4
subunit (from COX 4–1 to COX 4–2) through upregulation of LON, a mitochondrial protease under hypoxia.
Conclusions: We showed that leukemia cells survive and adapt to the hypoxic condition through various pathways.
Our results will help understanding energy metabolism of leukemia cells and creating novel therapeutics.
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Hematopoietic stem cells are localized in bone marrow,
where oxygen supply is limited. Hematopoietic stem cells
(HSCs) in hypoxic bone marrow have been demonstrated
to generate ATPs by anaerobic glycolysis rather than mito-
chondrial oxidative phosphorylation [1,2]. It has recently
been shown that characteristics of HSCs such as cell cycle
quiescence and transplantation capacity are secured by
glycolytic metabolic status through pyruvate dehydrogen-
ase kinase (PDK)-dependent mechanism [3]. It has been
demonstrated that the bone marrow microenvironment
also plays a pivotal role in the initiation and propagation of
leukemia. Leukemic cells can infiltrate the microenviron-
ment (niche) and may hijack the homeostatic mechanisms
of normal hematopoiesis, leading to enhanced self-renewal
and proliferation, quiescence, and resistance to chemo-
therapeutic agents [4-6].
It has been demonstrated that reactive oxygen species
(ROS) is generated by mitochondria under hypoxic condi-
tions [7-10]. Like normal hematopoietic stem cells,
leukemia stem cells are characterized by relatively low
levels of ROS (ROS-low) [11-13]. However, ROS can
modulate the activation of signal transduction pathways
involved in cellular proliferation and differentiation [14].
We also examined the contribution of ROS to the growth
of leukemia cells under hypoxia.
Recent studies have indicated that some cancer cells
do not dependent on glycolysis but on oxidative phos-
phorylation (OXPHOS) in mitochondria [12,15]. Some
reports indicated that cancer cell subsets with different
dependencies in energy generating pathways coexist
within tumors in a symbiotic manner [16,17].
We previously described that energy metabolism of
leukemia cells under normoxia and found that some
leukemia cell lines depended on glycolysis and others on
OXPHOS [18-20]. In these reports, we noted the neces-
sity of studying the energy metabolism under hypoxia
such as bone marrow environment where leukemia cells
proliferate, which has rarely been reported. Here, we
examined the growth and energy metabolism of leukemia
cells under hypoxia to clarify how leukemic cells survive
and proliferate in hypoxic bone marrow.
Methods
Cell line
Four acute myelogenous leukemia (AML) cell lines were
used in this study. NB4, a t(15;17) APL cell line, was pro-
vided by Dr. M. Lanotte (Saint Louis Hospital, France).
Kasumi-1, a t(8;21) AML cell line, was provided by Dr.
N. Kamada (Hiroshima University, Japan). THP-1, a
monocytic AML cell line, and HL-60, a differentiative
AML cell line were provided from Cell Resource Center
for Biomedical Research (Tohoku University, Japan). It
was confirmed that all cell lines were the same as thecells registered in Japanese Collection of Research Bio-
resources (JCRB) Cell Bank (Osaka, Japan), by the compari-
son with the database of JCRB cell bank. Cell lines were
usually grown in RPMI1640 medium containing 10% fetal
calf serum (FCS, Thermo Electron, Melbourne, Australia) in
humidified atmosphere of 5% CO2 and 95% air at 37°C.
Cell cultures
Cell line cells in logarithmic growth were cultured at the
density of 2 × 105/ml (0.5 ml RPMI1640 containing 3%
FCS/well) in tissue culture plate, 24 wells (Becton Dick-
inson, NJ, USA) under normoxia (21% O2) or hypoxia
(1% O2). Then, cell number was estimated at 24 hours
and at 48 hours by Particle Analyzer (PA-2000, Erma
Inc., Japan). Cell line cells were cultured in the same
condition with various concentrations of 2-fluoro-2-
deoxy-D-glucose (2-FDG: Sigma #F5006) (2, 5 and
10 mM) or oligomycin (oligo: Sigma #O4876) (0.05, 0.2
and 1 μg/ml) or N-acetyl-L-cysteine (NAC: Sigma
#A7250) (0.5 mM). Control culture containing same
amount of solvent (H2O for 2-FDG, DMSO for oligo)
was done simultaneously. After 24 or 48 hours culture,
cell number was estimated by Particle Analyzer.
Enzymatic measurement of glucose, lactic acid
Cell lines were cultured in the same condition as in the
section of Cell Cultures for 48 hours. Then, concentra-
tion of glucose and lactic acid in the culture supernatant
was measured by using D-Glucose kit or L-Lactic acid
kit (UV method: R-Biopharm AG, Darmstadt, Germany).
Glucose consumption was calculated as follows: [glucose
consumption (g/l)] = [glucose concentration of cell free
medium = 1.92 (g/l)] – [measured glucose concentration
after culture (g/l)]. Lactate production (g/l) was defined
as measured lactate concentration after culture (g/l),
since cell free medium did not contain lactate.
Apoptosis assay
After 12 or 24 hours culture in the same condition as in
the section of Cell Cultures, apoptosis of NB4 and THP-1
was examined by annexin V / propidium iodide (PI) stain-
ing (TACS Annexin V-FITC Apoptosis Detection Kit,
TREVIGEN, Gaithersburg, MD), and analyzed by flow cyt-
ometer (FACS Canto II, BD Biosciences, San Jose, CA).
Annexin V positive cells were defined as apoptotic cells,
and annexin V negative and PI negative (annexin-/PI-)
cells were defined as viable cells. The viable cell number
with or without NAC (0.5 mM) were examined after
48 hours culture.
ROS and GSH (reduced glutathione) / GSSG (oxidized
glutathione) measurements
After 48 hours culture in the same condition as in the
section of Cell Cultures with or without NAC (0.5 mM),
Figure 1 Cell proliferation of four leukemia cell lines with no treatment under normoxia or hypoxia. 2 × 105/ml cells in 0.5 ml RPMI1640 +
3% FCS were cultured under normoxia (21% O2) or hypoxia (1% O2) for 48 hours in triplicate. Then, cell count was measured after 24 and 48 hours,
respectively. NB4 (A) significantly diminished their proliferation under hypoxia compared with normoxia (48 hours) (p = 0.0001). In contrast, THP-1
(B) significantly increased more under hypoxia than normoxia (48 hours) (p = 0.005). Kasumi-1 (C) and HL-60 (D) did not show significant difference of cell
growth between normoxia and hypoxia (48 hours).▲: under hypoxia, ●: under normoxia. *** p < 0.001, ** p < 0.01, ns p > 0.05 (unpaired, two-tailed t-test).
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ration, CA) (1 μM) was added and incubated for 30 min,
then washed and analyzed by flow cytometry to detect
ROS level.
After 24 hours culture at the density of 2 × 105/ml
(0.02 ml RPMI1640 containing 3% FCS/each well) in
tissue cluture plate, 96 wells, U-bottom (Becton Dickin-
son, NJ, USA) under normoxia or hypoxia (short term
hypoxia: SH), cells were collected and assayed for GSH /
GSSG-Glo Assay (Promega, USA). After 7 days culture
under hypoxia with two medium changes, GSH / GSSG
measurement was also done using these cells cultured for
24 more hours under hypoxia (long term hypoxia: LH).Figure 2 Apoptosis assay by annexin V staining under hypoxia versu
same condition as cell proliferation assay for 24 hours in triplicate. Then, ap
method. Apoptotic cells of NB4 (A) under 24 hours hypoxia were significan
apoptosis under hypoxia at least 24 hours (p = 0.7876).▲: under hypoxia, ●
ns p > 0.05 (unpaired, two-tailed t-test).Reverse transcriptase- polymerase chain reaction (PCR)
After 24 hours culture under normoxia or hypoxia, total
RNA was isolated from NB4 and THP-1 using RNeasy
Mini Kit (Qiagen, Germany). 1 μg of total RNA was re-
verse transcribed using random hexamer priming and
SuperScriptIII reverse transcriptase (Life Technologies,
Carlsbad, CA) to generate cDNA. Then, PCR was done
using KOD FX Neo (TOYOBO, Osaka, Japan) with 50 ng
cDNA in the following conditions: After predenature at
94°C for 2 min, 15 sec at 98°C, 30 sec at 53°C, 15 sec at
68°C (28 cycles) for COX 4 isoform 1 (4–1); After prede-
nature at 94°C for 2 min, 15 sec at 98°C, 30 sec at 57°C,
20 sec at 68°C (38 cycles) for COX4 isoform 2 (4–2); Afters normoxia on NB4 and THP-1. NB4 and THP-1 were cultured in the
optotic cells were examined after 12 and 24 hours by annexin V / PI
tly increased (p = 0.0031), although THP-1 (B) did not show increased
: under normoxia. H: under hypoxia, N: under normoxia. *** p < 0.001,
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56°C, 20 sec at 68°C (28 cycles) for LON; After predena-
ture at 94°C for 2 min, 10 sec at 98°C, 30 sec at 58°C,
18 sec at 68°C (25 cycles) for β-actin. Primers for PCR
were as follows: COX 4–1 Fw 5′-GAGCAATTTC-
CACCTCTG-3′, Rev 5′-CAGGAGGCCTTCTCCTT
CTC-3′, COX 4–2 Fw 5′-GCTATGCCCAGCGCTACTA
C-3′, Rev 5′-CATCTCCGCAAAGGTCTCAT-3′, LON
Fw 5′-CGGGAAGATCATCCAGTGTT-3′, Rev 5′-ACG
TCCAGGTAGTGGTCCAG-3′ and β-actin (as a control
gene) Fw 5′-CGGCGACGACCCATTCGAAC-3′, Rev 5′-
GAATCGAACCCTGATTCCCCGTC-3′.
Western blot
After 24 hours culture under normoxia or hypoxia, 1 × 106
cells of NB4 or THP-1 were lysed in 0.1 ml Blue Loading
Buffer Pack (Cell Signaling #7722, Danvers, MA) and
0.02 ml of lysed cells were electrophoresed in 7.5% poly-
acrylamide gel. The gel was electroblotted onto hybond-P
(GE Healthcare, UK). The membrane was hybridized with
antibody to PDK1 (mouse monoclonal antibody, IgG1:
abcam #ab110335, UK) at 1:1000 dilution and reacted with
anti-mouse IgG secondary antibody (Cell Signaling #7076,Figure 3 ROS and its effects on the viability of NB4 and THP-1 under
cell proliferation assay for 48 hours with or without NAC 0.5 mM. ROS leve
numbers of NB4 and THP-1 with or without NAC 0.5 mM were examined b
higher under 48 hours hypoxia (red line) than normoxia (black line). Incu
(blue line). NAC treatment increased viable cells cultured under hypoxia
under normoxia (p = 0.0285) (B left). On the other hand, THP-1 did not s
as same as NB4 (C, D). black line: ROS level under normoxia as control,
hypoxia, N: under normoxia. *** p < 0.001, * p < 0.05, ns p > 0.05 (unpaireDanvers, MA) at 1:2000 dilution. The membrane was
visualized by ECL-prime Detection System (GE Health-
care, UK). β-actin (horseradish peroxidase-conjugated
rabbit monoclonal antibody, IgG: Cell Signaling #5125,
Danvers, MA) was also tested as control.
Statistical analysis
The statistical analyses were done by t-test (unpaired, two-
tailed) using Graph Pad Prism software. Data were pre-
sented as mean ± SEM of three independent experiments.
Results
Proliferation of leukemia cell line cells under hypoxia
versus normoxia
To investigate the proliferation of leukemia cell line cells
under hypoxia, the number of four leukemia cell line
cells was estimated under normoxia or hypoxia after 24
and 48 hours incubation (Figure 1). NB4 grew more than
other three leukemia cell lines under normoxia. How-
ever, the proliferation of NB4 under hypoxia was less
than that under normoxia (p = 0.0001). After 48 hours
culture, only THP-1 grew more under hypoxia than
under normoxia (p = 0.005). HL-60 and Kasumi-1 didhypoxia. NB4 and THP-1 were cultured in the same condition as
ls were measured by using CellROX Deep Red Reagent. The viable cell
y annexin V / PI method in triplicate. ROS level of NB4 (A) was much
bation with NAC made ROS level decreased in NB4 under hypoxia
(p = 0.0002) (B right), although the effect of NAC was not so obvious
how ROS increase under hypoxia and addition of NAC did not work
red line: under hypoxia, blue line: under hypoxia with NAC. H: under
d, two-tailed t-test).
Figure 4 GSH / GSSG ratio measurement under normoxia and
two different terms of hypoxia. 2 × 105/ml cells in 0.02 ml
RPMI1640 + 3% FCS were cultured under normoxia (21% O2) or
hypoxia (1% O2) (short term hypoxia) for 24 hours in triplicate.
Then, GSH / GSSG ratio was measured by using GSH / GSSG-Glo
Assay. After 7 days culture under hypoxia with two medium changes,
GSH / GSSG ratio was also measured by using these cells cultured for
24 more hours under hypoxia (long term hypoxia). GSH / GSSG ratio of
NB4 under normoxia was 3.02 ± 0.067 and that under short term hypoxia
was 2.31 ± 0.020 (p = 0.0005). GSH / GSSG ratio under long term hypoxia
(2.69 ± 0.028) was significantly higher than that of short term hypoxia (p
= 0.0004). GSH / GSSG ratio of THP-1 under normoxia (1.50 ± 0.094) and
hypoxia (1.50 ± 0.083) was almost equal. THP-1 under longer hypoxia
showed increase of GSH / GSSG ratio (2.09 ± 0.077) compared with that
under short term hypoxia (p = 0.0065). SH: under short term hypoxia, LH
under long term hypoxia, N: under normoxia. *** p < 0.001, ** p < 0.01,
* p < 0.05, ns p > 0.05 (unpaired, two-tailed t-test).
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culture under normoxia and hypoxia (HL-60 p = 0.1906;
Kasumi-1 p = 0.1161). Then, we compared NB4 and
THP-1 under hypoxia to understand the influence of
hypoxia on leukemia cell growth.
Apoptosis assay under hypoxia versus normoxia
After 24 hours culture under hypoxia, NB4 showed sig-
nificant increase of apoptotic cells when compared with
that under normoxia (p = 0.0031) (Figure 2A). However,
there was no increase of annexin V positive cells in
THP-1 after 24 hours culture under hypoxia (p = 0.7876)
(Figure 2B).
ROS measurement and the effects of ROS scavenger
Since some reports indicated that ROS was increased
under hypoxia, we determined the ROS level of NB4 and
THP-1 under normoxia and hypoxia. ROS level was much
higher in NB4 under 48 hours hypoxia than normoxia.
Moreover, incubation with NAC as ROS scavenger made
ROS level decreased in NB4 under hypoxia (Figure 3A). In
addition, NAC treatment increased viable cells cultured
under hypoxia (p = 0.0002), although the effect of NAC was
not so obvious under normoxia (p = 0.0285) (Figure 3B). On
the other hand, THP-1 did not show ROS increase under
hypoxia and addition of NAC did not work as same as NB4
(Figure 3C and D).
GSH / GSSG measurement
To evaluate oxidative stress such as ROS, we performed
GSH / GSSG ratio measurement. We compared normoxia
to hypoxia (short term or long term) in NB4 and THP-1.
GSH / GSSG ratio of NB4 under normoxia was 3.02 ± 0.067
and that of NB4 under hypoxia was 2.31 ± 0.020, suggesting
that NB4 under hypoxia had much oxidative stress. GSH /
GSSG ratio of NB4 under long term (7 days) hypoxia (the
ratio was 2.69 ± 0.028) was higher than short term (24 hours)
hypoxia (the ratio was 2.31 ± 0.020). GSH / GSSG ratio
of THP-1 under normoxia (1.50 ± 0.094) and hypoxia
(1.50 ± 0.083) was almost equal, suggesting that THP-1
had equal oxidative stress regardless of oxygen concen-
tration. THP-1 under longer hypoxia showed increase
of GSH / GSSG ratio (the ratio was 2.09 ± 0.077)
(Figure 4).
Glucose consumption and lactate production
Glucose consumption of NB4 under normoxia (for
48 hours) was 0.6589 ± 0.04879 g/l and that under hypoxia
was 1.056 ± 0.00552 g/l, respectively. In THP-1, glucose
consumption under normoxia (for 48 hours) was 0.2258
± 0.01804 g/l and that under hypoxia was 0.4366
±0.03404 g/l, respectively. Both cell lines had significant
difference between normoxia and hypoxia in glucose
consumption (p = 0.0013 in NB4, p = 0.0054 in THP-1)(Figure 5A). Then, lactate production of NB4 under
normoxia (for 48 hours) was 0.6847 ± 0.01780 g/l and
that under hypoxia was 0.7323 ± 0.006692 g/l, which
were not significantly different (p = 0.0663). In THP-1,
lactate production under normoxia (for 48 hours) was
0.3010 ± 0.003512 g/l and that under hypoxia was
0.4663 ± 0.004096 g/l, where the difference was signifi-
cant (p < 0.0001) (Figure 5B).
Growth inhibition with 2-FDG or oligo under hypoxia
versus normoxia
The cell count assay with 2-FDG as a glycolysis inhibitor
was performed on NB4 and THP-1 under normoxia and
hypoxia. The growth suppression of THP-1 by 2-FDG
even at 2 mM under hypoxia was significantly more pro-
nounced than that under normoxia, although the growth
inhibition of NB4 by 2-FDG under hypoxia was slightly
less than that under normoxia (Figure 6A).
Figure 5 Glucose consumption and lactate production in NB4 and THP-1 under normoxia versus hypoxia. NB4 and THP-1 were cultured in
the same condition as cell proliferation assay for 48 hours in triplicate. Then, concentration of glucose and lactic acid in the culture supernatant was
measured by using D-Glucose kit or L-Lactic acid kit. Both cell lines showed increased glucose consumption under hypoxia compared with normoxia
with statistical significance (p = 0.0013 in NB4, p = 0.0054 in THP-1) (A). THP-1 demonstrated increased lactate production under hypoxia (p < 0.0001),
but NB4 did not (p = 0.0663) (B). H: under hypoxia, N: under normoxia. *** p < 0.001, ** p < 0.01, ns p > 0.05 (unpaired, two-tailed t-test).
Figure 6 Growth inhibition by 2-FDG or oligo on NB4 and THP-1 under normoxia and hypoxia. NB4 and THP-1 were cultured in the same
condition as cell proliferation assay for 48 hours with 2-FDG (0, 2, 5 10 mM) or oligo (0, 0.05, 0.2, 1 μg/ml) in triplicate. The cell numbers after
48 hours culture under normoxia or hypoxia with 2-FDG or oligo were divided by cell numbers of control (average of triplicated experiments) to
obtain cell number ratios, in which the cell number with no treatment corresponded to 100%. The growth suppression of THP-1 by 2-FDG even
at 2 mM under hypoxia was significantly more pronounced than that under normoxia (p = 0.0005), although the growth inhibition of NB4 by
2-FDG under hypoxia was slightly less than that under normoxia (A). Oligo did not suppress the growth of NB4 under hypoxia, but suppressed
that under normoxia (at 1 μg/ml, p < 0.0001). Oligo similarly suppressed the growth of THP-1 under normoxia and hypoxia (B). ▲: under hypoxia,
●: under normoxia. *** p < 0.001, ** p < 0.01, ns p > 0.05 (unpaired, two-tailed t-test).
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dative phosphorylation inhibitor was performed on NB4
and THP-1 under normoxia and hypoxia. Oligo did not
suppress the growth of NB4 under hypoxia, but sup-
pressed that under normoxia (p < 0.0001). Oligo similarly
suppressed the growth of THP-1 under normoxia and
hypoxia (Figure 6B).Figure 8 RT-PCR analysis of COX 4–1 and LON on NB4 and
THP-1 under normoxia or hypoxia. NB4 and THP-1 were cultured
in the same condition as cell proliferation assay for 24 hours. The
expression of COX 4–1 in THP-1 under hypoxia was decreased
compared with normoxia. In addition, mRNA expression of LON in
THP-1 under hypoxia was increased compared with that in
normoxia. In NB4, mRNA expression of COX 4–1 and LON was not
influenced by O2 concentration. β-actin was performed as an
internal control. Top, COX 4–1; middle, LON; bottom, β-actin.
H: under hypoxia, N: under normoxia.Western blotting for detecting upregulation of PDK1
PDK1 inactivates pyruvate dehydrogenase (PDH) com-
plex and leads to suppression of the influx of glycolytic
metabolites into mitochondria. PDK1 is induced by hy-
poxia in normal cell for adaptation to hypoxia and often
expressed constantly in some cancer. Western blot
showed that PDK1 was abundantly expressed in NB4
even under normoxia, and culture under hypoxia did
not augment the expression of PDK1 in NB4. Expression
of PDK1 was augmented by hypoxia in THP-1, which
was demonstrated by western blotting (Figure 7).mRNA expression of COX 4 and mitochondrial protease
LON
It has been demonstrated that expression of the COX 4–1
and 4–2 isoforms is O2 regulated. Under hypoxia, isoform
is switched from COX 4–1 to COX 4–2 by inducing
LON, a mitochondrial protease that is required for COX
4–1 degradation to optimize the efficiency of respiration
at low O2 concentration [21]. As shown in Figure 8,
mRNA expression of COX 4–1 in THP-1 under hypoxia
was decreased compared with that in normoxia. In
addition, mRNA expression of LON in THP-1 under hyp-
oxia was increased compared with that in normoxia. In
this experiment, mRNA expression of COX 4–2 could not
be detected even repeated experiments. In NB4, mRNA
expression of COX 4–1 and LON was not influenced by
O2 concentration.Figure 7 Western blotting of PDK1. NB4 and THP-1 were cultured
in the same condition as cell proliferation assay for 24 hours. PDK1
was abundantly expressed in NB4 even under normoxia, culture
under hypoxia did not augment the expression of PDK1 in NB4.
Expression of PDK1 was augmented by hypoxia in THP-1. Top,
PDK1; bottom, β-actin. H: under hypoxia, N: under normoxia.Discussion
Recently, inhibiting glycolysis draws attention as novel
cancer therapeutics. Since there are alternative pathways
to overcome energy depletion by glycolysis inhibition
[12,15], the effectiveness of anti-glycolysis therapy alone
is controversial. We thought therapeutic strategies tar-
geting leukemia cell metabolism would be improved by
studying energy metabolism more precisely, especially
under hypoxia where leukemia cells grow.
We examined the proliferation of leukemia cell line
cells under hypoxia and compared with that under nor-
moxia. NB4, an APL cell line, which mainly depends on
glycolysis for energy production [18-20], demonstrated
prominent apoptosis and growth suppression after
48 hours culture under hypoxia. It was contrary to our
expectation that NB4, already dependent on glycolysis,
would proliferate well under hypoxia. However, NB4
utilizes OXPHOS in mitochondria to some extent for
energy production, which is validated by growth sup-
pression with oligo treatment. Then, we examined the
ROS, since it has been demonstrated that ROS is gener-
ated by mitochondria under hypoxic conditions [7-10]
and checked if apoptosis induced by hypoxia is caused by
increased ROS. NB4 cells cultured under hypoxia showed
significantly increased ROS and culture with NAC, a
ROS scavenger or oligo, an inhibitor of OXPHOS in
mitochondria resulted in decrease of apoptotic cell death
of NB4 under hypoxia. However, leukemia cells prolife-
rate in hypoxic bone marrow. NB4 cells cultured for
longer period (7 days) under hypoxia did not come
to extinction, but grew slowly. NB4 cells cultured
under hypoxia for longer period showed improved
GSH / GSSG ratio compared with shorter hypoxia.
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bone marrow by upregulating GSH synthesis to protect
from ROS generated in hypoxic condition.
THP-1 showed more growth under hypoxia than nor-
moxia. THP-1 largely depended on OXPHOS in mito-
chondria when grown under normoxia [18-20]. However,
we demonstrated that THP-1 changed the main energy
metabolism from OXPHOS to glycolysis by upregulating
PDK1 under hypoxia. THP-1 consumed more glucose and
produced more lactate under hypoxia than normoxia, and
the growth of THP-1 was significantly more suppressed
by a glycolysis inhibitor, 2-FDG under hypoxia. However,
oligo suppressed the growth of THP-1 under hypoxia to
the almost same extent as under normoxia, which means
that OXPHOS in mitochondria is still functional under
hypoxia. If OXPHOS in mitochondria is functional under
hypoxia, ROS would be produced to induce apoptosis like
NB4. However, ROS was not increased under hypoxia in
THP-1. We thought that THP-1 has mechanisms to avoid
ROS generation under hypoxia. Since Fukuda et al. de-
monstrated that cancer cells survive hypoxic condition by
COX 4 subunit exchange to minimize ROS production,
we examined COX 4 system. We found that in THP-1
under hypoxia, expression of COX 4–1 was decreased and
LON, a mitochondrial protease that might be required for
COX 4–1 degradation, is upregulated (switched from
COX 4–1 to COX 4–2) to avoid ROS generation by ef-
ficient electron transport under hypoxia. We could not
detect COX 4–2 expression, which might be due to
paucity of expression in hematopoietic cells [22].
From our observation described here, leukemia cells
survive environmental change such as hypoxia by vari-
ous mechanisms. Determining detailed metabolic system
would lead to novel leukemia therapy suitable for each
leukemia cells, for example, inhibition of GSH produc-
tion for NB4 and inhibition of LON protease for THP-1
under hypoxia.
Conclusions
We have demonstrated that leukemia cells do not always
depend on glycolysis for energy production but on
OXPHOS, and present study have shown that leukemia
cells survive and adapt to the hypoxic condition through
various pathways; scavenging ROS or metabolism switch
by upregulating PDK1 and COX 4 subunit exchange.
The concept of targeting cancer metabolism has
emerged as an intriguing approach to the development
of improved therapeutic regimens. Understanding fur-
ther the metabolic regulation of leukemia cells may yield
improved therapeutic strategies.
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